# Ocular Therapeutix Inc. – FDA Inspection, Oct 26, 2018

Source: https://www.keypedia.com/records/fda_inspections/ocular-therapeutix-inc/7d7e78ec-1c79-4ff5-8b2e-126fae76893a
Source feed: FDA_Inspections

> FDA inspection 1069931 of Ocular Therapeutix Inc., October 26, 2018. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 211. Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1069931
- Company Name: Ocular Therapeutix Inc.
- Inspection Date: 2018-10-26
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: New Drug Evaluation
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New England District Office
- Citation Count: 3

## Related Documents

- FDA Inspection 1224953 - 2023-11-09
- [FDA Inspection 1012195 - 2017-05-04](https://www.keypedia.com/records/fda_inspections/ocular-therapeutix-inc/4f9c6795-174d-4757-afcf-b33cd125edee)
- FDA Inspection 964143 - 2016-02-11
- [FDA Inspection 918538 - 2015-03-11](https://www.keypedia.com/records/fda_inspections/ocular-therapeutix-inc/4ab005ed-ef77-4216-a3eb-f87983b53761)
- FDA Inspection 834075 - 2013-06-03

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/sean-r-marcsisin/45c910a9-9019-4419-9af8-b1c9f3b1e976)

Company: https://www.keypedia.com/companies/ocular-therapeutix-inc/6ba62c3c-398b-49a0-9075-c22aa736acdf

Office: https://www.keypedia.com/offices/new-england-district-office/aa458072-2f1d-4231-89f5-21ba7a3b7144